CCIA
WVE icon

Campbell & Co Investment Adviser’s Wave Life Sciences WVE Stock Holding History

Campbell & Co Investment Adviser’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-27,100
Closed -$85K – 933
2021
Q4 		$85K Buy
+27,100
New +$113K 0.03% 582

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Campbell & Co Investment Adviser's WVE Position: Q1 2022 in Review

Campbell & Co Investment Adviser sold out of Wave Life Sciences (WVE) in Q1 2022, closing a stake of 27,100 shares — an estimated $85K sold.

Campbell & Co Investment Adviser first reported a position in WVE in Q4 2021 and held it in 1 quarter. The position peaked at $85K in Q4 2021. 82 funds tracked by Wall St. Rank hold WVE as of Q1 2022.

  • Campbell & Co Investment Adviser reported no remaining Wave Life Sciences position as of Q1 2022 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 27,100 Wave Life Sciences shares in Q1 2022, an estimated $85K.
  • Campbell & Co Investment Adviser first reported a position in Wave Life Sciences in Q4 2021 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's Wave Life Sciences position peaked at $85K in Q4 2021.
  • 82 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2022.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2022, filed 9 May 2022.